Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on May 31, 2025

Investing.com

a day ago

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy

MT Newswires

2 days ago

Goldman Sachs Initiates Insulet at Buy With $380 Price Target

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

Simply Wall St.

3 days ago

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

MT Newswires

5 days ago

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Zacks

5 days ago

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Business Wire

9 days ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

Zacks

9 days ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

MT Newswires

9 days ago

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

4 Medical Product Stocks to Watch From a Challenging Industry

Zacks

10 days ago

4 Medical Product Stocks to Watch From a Challenging Industry

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Zacks

16 days ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

MT Newswires

16 days ago

Bernstein Adjusts Insulet Price Target to $375 From $355

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

17 days ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

MT Newswires

17 days ago

Insulet Insider Sold Shares Worth $960,320, According to a Recent SEC Filing

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Insider Monkey

17 days ago

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Outlier Money Flows Lift Insulet

FX Empire

17 days ago

Outlier Money Flows Lift Insulet

1 Mid-Cap Stock to Target This Week and 2 to Avoid

StockStory

18 days ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

Argus Research

18 days ago

PODD: Raising target price to $346.00

MT Newswires

19 days ago

Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating

Insulet Announces Publication of 2024 Sustainability Report

Business Wire

19 days ago

Insulet Announces Publication of 2024 Sustainability Report

MT Newswires

19 days ago

Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $350

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

Zacks

19 days ago

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

MT Newswires

20 days ago

Redburn Atlantic Adjusts Price Target on Insulet to $350 From $315, Maintains Buy Rating

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

Investor's Business Daily

21 days ago

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

Morningstar Research

22 days ago

Analyst Report: Insulet Corporation

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Investopedia

22 days ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Investor's Business Daily

22 days ago

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Why Insulet (PODD) Stock Is Trading Up Today

StockStory

22 days ago

Why Insulet (PODD) Stock Is Trading Up Today

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Investopedia

22 days ago

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Yahoo Finance Video

22 days ago

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Simply Wall St.

22 days ago

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

Investopedia

22 days ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MT Newswires

22 days ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

Thomson Reuters StreetEvents

22 days ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

Investor's Business Daily

22 days ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

MT Newswires

22 days ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

MT Newswires

22 days ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

MT Newswires

22 days ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

MT Newswires

22 days ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

MT Newswires

22 days ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

What To Expect From Insulet’s (PODD) Q1 Earnings

StockStory

25 days ago

What To Expect From Insulet’s (PODD) Q1 Earnings

Argus Research

25 days ago

PODD: Raising target price to $285.00

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Zacks

a month ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

StockStory

a month ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

MT Newswires

a month ago

Insulet Shares Fall After Wolfe Research Downgrade

MT Newswires

a month ago

Wolfe Research Downgrades Insulet to Peer Perform From Outperform

Insulet Names New CEO, Expects to Top Revenue Projections

Investopedia

a month ago

Insulet Names New CEO, Expects to Top Revenue Projections

Ashley McEvoy named Insulet CEO

MedTech Dive

a month ago

Ashley McEvoy named Insulet CEO

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

StockStory

a month ago

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

MT Newswires

a month ago

Insulate Names Ashley McEvoy Chief Executive

Insulet Appoints Ashley McEvoy President and CEO

Business Wire

a month ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

a month ago

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Argus Research

a month ago

PODD: Raising target price to $297.00

4 Medical Product Stocks to Buy From a Challenging Industry

Zacks

a month ago

4 Medical Product Stocks to Buy From a Challenging Industry

Argus Research

a month ago

PODD: Raising target price to $282.00

MT Newswires

2 months ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory

2 months ago

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Zacks

2 months ago

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Zacks

2 months ago

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Argus Research

2 months ago

PODD: Lowering target price to $272.00

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Zacks

2 months ago

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

2 months ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Investor's Business Daily

2 months ago

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

MT Newswires

2 months ago

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group

2 months ago

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire

2 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

2 months ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Argus Research

2 months ago

PODD: Lowering target price to $290.00

3 Reasons Investors Love Insulet (PODD)

StockStory

2 months ago

3 Reasons Investors Love Insulet (PODD)

MT Newswires

2 months ago

Insulet Insider Sold Shares Worth $501,875, According to a Recent SEC Filing

Argus Research

2 months ago

PODD: Rating increased to a BUY

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Zacks

2 months ago

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks

2 months ago

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

2 months ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

Zacks

2 months ago

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Zacks

2 months ago

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MedTech Dive

2 months ago

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MT Newswires

2 months ago

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Business Wire

2 months ago

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

Zacks

2 months ago

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

MT Newswires

2 months ago

Insulet Prices $450 Million Senior Notes Due 2033

Insulet Announces Pricing of Senior Notes Due 2033

Business Wire

2 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey

2 months ago

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insulet Chief Technology Officer Mark Field leaves

MedTech Dive

2 months ago

Insulet Chief Technology Officer Mark Field leaves

MT Newswires

2 months ago

Insulet Plans $450 Million Senior Notes Offering

MT Newswires

2 months ago

Insulet Launches Omnipod 5 Insulin Delivery System in Australia

Insulet Expands Omnipod® 5 to Four More International Markets

Business Wire

2 months ago

Insulet Expands Omnipod® 5 to Four More International Markets

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Business Wire

2 months ago

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Simply Wall St.

3 months ago

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Insulet to Host Investor Day on June 5, 2025

Business Wire

3 months ago

Insulet to Host Investor Day on June 5, 2025

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Simply Wall St.

3 months ago

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

TipRanks

3 months ago

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

MT Newswires

3 months ago

RBC Initiates Insulet at Outperform With $340 Price Target

Argus Research

3 months ago

PODD: Raising target price to $283.00

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

MedTech Dive

3 months ago

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

StockStory

3 months ago

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

Insulet Sales Keep Rising

FX Empire

3 months ago

Insulet Sales Keep Rising

Share on Social Networks: